Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis - Sandborn, WJ; Ferrante, M; Bhandari, BR (Clin Gastroenterol Hepatol, 2022)
et al.